{"title":"Consistency of Radiological Staging in Resectable Mismatch-Repair Proficient Colon Cancer: An Interobserver Agreement Study","authors":"Vincenzo Nasca , Gabriele Tinè , Marta Vaiani , Raffaella Vigorito , Francesca Gabriella Greco , Alessandra Casale , Gaetano Ramondo , Alessandro Rago , Luigi Asmundo , Cristiano Sgrazzutti , Dania Cioni , Roberto Francischello , Emanuele Neri , Marco Calandri , Carolina Sciortino , Laura Sanchez , Margherita Ambrosini , Isacco Montroni , Federica Marmorino , Chiara Cremolini , Giovanni Randon","doi":"10.1016/j.clcc.2026.01.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Reproducibility and accuracy of radiological classification with CT imaging is crucial for selecting patients with resectable, nonmetastatic colon cancer (CC) who may benefit from neoadjuvant strategies.</div></div><div><h3>Methods</h3><div>We evaluated interobserver agreement among 4 independent radiology equipes in classifying patients with resectable, nonmetastatic, mismatch repair proficient CC with available preoperative CT imaging. Radiology equipes were blinded to clinical and pathological data, and categorized tumors according to FOxTROT and Node-RADS criteria, classifying T (T1/2, T3, T4, including stratification by extramural invasion [EMI]) and N status. The primary endpoint was interobserver agreement (Cohen’s κw); secondary endpoints included concordance with pathological staging and diagnostic performance metrics. Bayesian and cross-validation analyses assessed robustness.</div></div><div><h3>Results</h3><div>Among 109 patients (32.1% pT2, 33.9% pT3, 33.9% pT4; 45.9% pN0/1c, 54.1% pN1-2), overall interobserver agreement indicated inadequate concordance for both cT (κw = 0.56; 95% CI, 0.43-0.68) and cN category (κw = 0.51; 95% CI, 0.36-0.66). Of 109 patients, 38 (35%) were classified identically for T stage by all 4 Radiology groups, while 74 (68%) showed some disagreement. When considering risk stratification into high risk (cT3 with EMI ≥5 mm or cT4) versus low risk (cT1/cT2 or cT3 with EMI <5 mm) 56 patients (51%) received the same classification all 4 groups, and 95 patients (87%) were classified consistently by at least 3 groups. Overall concordance between radiology and pathological staging was inadequate for both T (κw = 0.47; 95% CI, 0.35-0.57) and N staging (κw = 0.16; 95% CI, 0.07-0.33). The mean sensitivity and specificity of CT scan for pT3/T4 and pT4 were 72%/78% and 33%/93%.</div></div><div><h3>Conclusions</h3><div>Identification of high-risk features in resectable CC by CT scan should be implemented to guide patients’ selection for neoadjuvant therapies.</div></div>","PeriodicalId":10373,"journal":{"name":"Clinical colorectal cancer","volume":"25 2","pages":"Pages 239-248.e6"},"PeriodicalIF":2.7000,"publicationDate":"2026-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical colorectal cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1533002826000071","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/2/5 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Reproducibility and accuracy of radiological classification with CT imaging is crucial for selecting patients with resectable, nonmetastatic colon cancer (CC) who may benefit from neoadjuvant strategies.
Methods
We evaluated interobserver agreement among 4 independent radiology equipes in classifying patients with resectable, nonmetastatic, mismatch repair proficient CC with available preoperative CT imaging. Radiology equipes were blinded to clinical and pathological data, and categorized tumors according to FOxTROT and Node-RADS criteria, classifying T (T1/2, T3, T4, including stratification by extramural invasion [EMI]) and N status. The primary endpoint was interobserver agreement (Cohen’s κw); secondary endpoints included concordance with pathological staging and diagnostic performance metrics. Bayesian and cross-validation analyses assessed robustness.
Results
Among 109 patients (32.1% pT2, 33.9% pT3, 33.9% pT4; 45.9% pN0/1c, 54.1% pN1-2), overall interobserver agreement indicated inadequate concordance for both cT (κw = 0.56; 95% CI, 0.43-0.68) and cN category (κw = 0.51; 95% CI, 0.36-0.66). Of 109 patients, 38 (35%) were classified identically for T stage by all 4 Radiology groups, while 74 (68%) showed some disagreement. When considering risk stratification into high risk (cT3 with EMI ≥5 mm or cT4) versus low risk (cT1/cT2 or cT3 with EMI <5 mm) 56 patients (51%) received the same classification all 4 groups, and 95 patients (87%) were classified consistently by at least 3 groups. Overall concordance between radiology and pathological staging was inadequate for both T (κw = 0.47; 95% CI, 0.35-0.57) and N staging (κw = 0.16; 95% CI, 0.07-0.33). The mean sensitivity and specificity of CT scan for pT3/T4 and pT4 were 72%/78% and 33%/93%.
Conclusions
Identification of high-risk features in resectable CC by CT scan should be implemented to guide patients’ selection for neoadjuvant therapies.
期刊介绍:
Clinical Colorectal Cancer is a peer-reviewed, quarterly journal that publishes original articles describing various aspects of clinical and translational research of gastrointestinal cancers. Clinical Colorectal Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of colorectal, pancreatic, liver, and other gastrointestinal cancers. The main emphasis is on recent scientific developments in all areas related to gastrointestinal cancers. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.